Ms Rebecca Weiss, LAC | |
230 Old Forge Xing, Devon, PA 19333-1122 | |
(610) 864-8600 | |
Not Available |
Full Name | Ms Rebecca Weiss |
---|---|
Gender | Female |
Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
Location | 230 Old Forge Xing, Devon, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477732360 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | KO 00611 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Rebecca Weiss, LAC 230 Old Forge Xing, Devon, PA 19333-1122 Ph: (610) 864-8600 | Ms Rebecca Weiss, LAC 230 Old Forge Xing, Devon, PA 19333-1122 Ph: (610) 864-8600 |
News Archive
The risk of becoming overweight is 3.5 times higher in children who get less sleep than in those who sleep a lot, according to researchers Jean-Philippe Chaput, Marc Brunet, and Angelo Tremblay.
ImThera Medical, Inc. today announced interim results from its OSA European clinical study. For the study, ten patients have been surgically implanted with ImThera's aura6000 hypoglossal nerve neurostimulation device for treating Obstructive Sleep Apnea. The target population for ImThera's neurostimulation device is moderate and severe OSA patients who are non-compliant with or cannot tolerate Continuous Positive Airway Pressure.
Alexion Pharmaceuticals, Inc. today announced financial results for the three and nine months ended September 30, 2011.
EpiCept Corporation today announced that Nasdaq OMX Stockholm AB has approved the Company's request for a primary listing of its common stock on the Nasdaq OMX Stockholm Exchange.
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has approved the inclusion of data from two clinical studies in an update to the ONGLYZA U.S. Prescribing Information for adult type 2 diabetes patients.
› Verified 4 days ago